Krieg Sandro M, Sabih Jamil, Bulubasova Lucia, Obermueller Thomas, Negwer Chiara, Janssen Insa, Shiban Ehab, Meyer Bernhard, Ringel Florian
Department of Neurosurgery (S.M.K., J.S., L.B., T.O., C.N., I.J., E.S., B.M., F.R.); TUM-Neuroimaging Center, Klinikum rechts der Isar, TU München, Germany (S.M.K., J.S., L.B., T.O.).
Neuro Oncol. 2014 Sep;16(9):1274-82. doi: 10.1093/neuonc/nou007. Epub 2014 Feb 9.
Navigated transcranial magnetic stimulation (nTMS) has been proven to influence surgical indication and planning. Yet there is still no clear evidence how these additional preoperative functional data influence the clinical course and outcome. Thus, this study aimed to compare patients with motor eloquently located supratentorial lesions investigated with or without preoperative nTMS in terms of clinical outcome parameters.
A prospectively enrolled cohort of 100 patients with supratentorial lesions located in motor eloquent areas was investigated by preoperative nTMS (2010-2013) and matched with a control of 100 patients who were operated on without nTMS data (2006-2010) by a matched pair analysis.
Patients in the nTMS group showed a significantly lower rate of residual tumor on postoperative MRI (OR 0.3828; 95% CI 0.2062-0.7107). Twelve percent of patients in the nTMS and 1% of patients in the non-nTMS group improved while 75% and 81% of the nTMS and non-nTMS groups, respectively, remained unchanged and 13% and 18% of patients in the nTMS and non-nTMS groups, respectively, deteriorated in postoperative motor function on long-term follow-up (P = .0057). Moreover, the nTMS group showed smaller craniotomies (nTMS 22.4 ± 8.3 cm(2); non-nTMS 26.7 ± 11.3 cm(2); P = .0023).
This work increases the level of evidence for preoperative motor mapping by nTMS for rolandic lesions in a group comparison study. We therefore strongly advocate nTMS to become increasingly used for these lesions. However, a randomized trial on the comparison with the gold standard of intraoperative mapping seems mandatory.
导航经颅磁刺激(nTMS)已被证明会影响手术指征和规划。然而,目前仍没有明确证据表明这些额外的术前功能数据如何影响临床病程和结果。因此,本研究旨在比较术前接受或未接受nTMS检查的、运动功能区明确的幕上病变患者的临床结局参数。
对100例位于运动功能区的幕上病变患者进行前瞻性队列研究,于术前(2010 - 2013年)采用nTMS检查,并通过配对分析将其与100例无nTMS数据的手术患者(2006 - 2010年)进行匹配。
nTMS组患者术后MRI显示残留肿瘤的发生率显著较低(比值比0.3828;95%置信区间0.2062 - 0.7107)。nTMS组12%的患者病情改善,非nTMS组为1%;在长期随访中,nTMS组和非nTMS组分别有75%和81%的患者病情无变化,nTMS组和非nTMS组分别有13%和18%的患者术后运动功能恶化(P = 0.0057)。此外,nTMS组的开颅范围较小(nTMS组22.4 ± 8.3 cm²;非nTMS组26.7 ± 11.3 cm²;P = 0.0023)。
在一项组间比较研究中,本研究提高了nTMS用于术前运动功能区定位以治疗中央前回病变的证据水平。因此,我们强烈主张越来越多地将nTMS用于这些病变。然而,与术中定位金标准进行比较的随机试验似乎是必要的。